Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals

Data suggest that coronavirus disease 2019 (COVID-19) results in a prothrombotic state leading to arterial and venous thromboses. Vaccination, novel antiviral drugs, and emerging variants have changed the course of the disease in many ways; however, their effects on the incidence of thrombotic event...

Descripción completa

Detalles Bibliográficos
Autores principales: Talasaz, Azita H., Sadeghipour, Parham, Mehdizadeh, Kasra, Khoshnam Rad, Niloofar, Bikdeli, Behnood, Lip, Gregory Y. H., Harenberg, Job
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904967/
https://www.ncbi.nlm.nih.gov/pubmed/36206775
http://dx.doi.org/10.1055/a-1956-9641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904967/
https://www.ncbi.nlm.nih.gov/pubmed/36206775
http://dx.doi.org/10.1055/a-1956-9641

Ejemplares similares